AU Patent

AU2020278162A1 — Processes and intermediates for preparing a BTK inhibitor

Assigned to Janssen Pharmaceutica NV · Expires 2021-11-18 · 4y expired

What this patent protects

Disclosed is a process for the preparation of certain intermediates, e.g. a process for preparing a compound of formula (I) wherein, R

USPTO Abstract

Disclosed is a process for the preparation of certain intermediates, e.g. a process for preparing a compound of formula (I) wherein, R

Drugs covered by this patent

Patent Metadata

Patent number
AU2020278162A1
Jurisdiction
AU
Classification
—
Expires
2021-11-18
Drug substance claim
No
Drug product claim
No
Assignee
Janssen Pharmaceutica NV
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.